论文部分内容阅读
作者应用间接移动抑制试验对自身免疫性慢性活动性肝炎(chronic active hepatitis,CAH)的抗原特异性T抑制细胞(Ts)功能进行了研究。结果表明,29例自身免疫性CAH(包括未经治疗的无活动性病变患者和经过治疗的有活动性病变患者),26例的淋巴细胞对肝特异性脂蛋白(1iver specificlipoprotein,LSP)产生了T淋巴细胞移动抑制因子(T lymphocyte migration inhibitory factor,T-LIF)。相比之下,21例HBsAg阳性慢性肝病中只有1例;健康对照组19例中无1例;5例自身免疫
The authors investigated the function of antigen-specific T suppressor (Ts) function in autoimmune chronic active hepatitis (CAH) using an indirect mobile inhibition test. Twenty-nine cases of autoimmune CAH (including untreated inactive disease and treated active disease) and 26 cases of lymphoid cells produced liver specific lipoprotein (LSP) T lymphocyte migration inhibitory factor (T-LIF). In contrast, only 21 cases of HBsAg-positive chronic liver disease in the healthy control group, 19 cases, 1 case, 5 cases of autoimmunity